MAXIMUS Stock Price, News & Analysis (NYSE:MMS)

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Wednesday, July 10th. Shareholders of record on Thursday, August 15th will be given a dividend of $0.25 per share on Friday, August 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date is Wednesday, August 14th. View MAXIMUS's Dividend History.

MAXIMUS declared that its board has initiated a share buyback program on Monday, June 25th 2018, which permits the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 4.9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings data on Thursday, August, 8th. The health services provider reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.04. The health services provider had revenue of $730.70 million for the quarter, compared to analyst estimates of $754.81 million. MAXIMUS had a net margin of 8.44% and a return on equity of 20.72%. The business's revenue was up 22.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 earnings per share. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Tuesday, November 19th 2019. View Earnings Estimates for MAXIMUS.

MAXIMUS issued an update on its FY19 earnings guidance on Thursday, August, 8th. The company provided earnings per share (EPS) guidance of $3.70-3.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.70. The company issued revenue guidance of $2.92 billion, compared to the consensus revenue estimate of prior $3.65-3.75.

2 Wall Street analysts have issued 1 year price objectives for MAXIMUS's stock. Their forecasts range from $77.00 to $83.00. On average, they expect MAXIMUS's stock price to reach $80.00 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for MAXIMUS.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Media coverage about MMS stock has trended somewhat negative this week, InfoTrie reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. MAXIMUS earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned media stories about the health services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for MAXIMUS.

MAXIMUS saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 1,613,100 shares, an increase of 14.6% from the July 31st total of 1,407,300 shares. Based on an average trading volume of 284,400 shares, the short-interest ratio is currently 5.7 days. Currently, 2.6% of the company's shares are sold short. View MAXIMUS's Current Options Chain.

Some companies that are related to MAXIMUS include Msci (MSCI), Ctrip.Com International (CTRP), Akamai Technologies (AKAM), Broadridge Financial Solutions (BR), LYFT (LYFT), The Western Union (WU), Fair Isaac (FICO), WEX (WEX), Nielsen (NLSN), Etsy (ETSY), Alliance Data Systems (ADS), Zillow Group (Z), Zillow Group (ZG), CDK Global (CDK) and CIELO S A/S (CIOXY).

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include AGNC Investment (AGNC), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Adamis Pharmaceuticals (ADMP), Broadcom (AVGO), ConforMIS (CFMS), JetBlue Airways (JBLU), NVIDIA (NVDA) and QUALCOMM (QCOM).

MAXIMUS's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.49%), BlackRock Inc. (11.49%), Vanguard Group Inc. (10.95%), Victory Capital Management Inc. (6.29%), Mackenzie Financial Corp (2.73%) and Van Berkom & Associates Inc. (2.03%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Renaissance Technologies LLC, Prudential Financial Inc., Panagora Asset Management Inc., AQR Capital Management LLC, Bank of New York Mellon Corp, Janus Henderson Group PLC and Janus Henderson Group PLC. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Nuveen Asset Management LLC, DekaBank Deutsche Girozentrale, William Blair Investment Management LLC, Skandinaviska Enskilda Banken AB publ, AXA, UBS Asset Management Americas Inc. and Mondrian Investment Partners LTD. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $78.03.

MAXIMUS has a market capitalization of $4.98 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.View Additional Information About MAXIMUS.

The official website for MAXIMUS is http://www.maximus.com/.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]